Comparison of long-term clinical effects of two different intraocular lenses in the treatment of pediatric cataract with posterior continuous curvilinear capsulorhexis and optic capture

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000041167

Enrollment

Unknown

Registered

2020-12-20

Start date

2020-12-20

Completion date

Unknown

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric cataract

Interventions

MIOL group:MIOL in the treatment of pediatric cataract with posterior continuous curvilinear capsulorhexis and optic capture

monofocal intraocular lens group:monofocal intraocular lens in the treatment of pediatric cataract with posterior continuous curvilinear capsulorhexis and optic capture

Eligibility

Sex/Gender

All

Age

2 Years to 16 Years

Inclusion criteria

Inclusion criteria: Children aged 2-14 years old with cataract (who can be treated with primary intraocular lens implantation).

Exclusion criteria

Exclusion criteria: 1. Patients who are participating in other clinical trials; 2. Patients with eye diseases or ocular diseases affect postoperative vision recovery, such as glaucoma ,retinal disease ,previous ocular surgeries,lens dislocation, history of ocular trauma ,central corneal opacities and iris deformity

Design outcomes

Primary

Measure	Time frame
Vision;Slit lamp inspection;pentcam;IOP;OQAS;examination of refraction;stereopsis testing;OCT;Photography of the anterior segment of dilated pupil;length of optic axis;	—

Countries

China

Contacts

Public ContactYushen Huang

Qingdao Eye Hosiptal

sdsykys@163.com+86 13791802251

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026